Navigation Links


detail at Biology News

Nonlinear Dynamics announces more details of its global partnership with PerkinElmer

Nonlinear Dynamics Ltd, a leading provider of bioinformatics solutions, today announced further details of its global OEM partnership with PerkinElmer, Inc. (NYSE: PKI), a leading provider of drug discovery, life science research and analytical solutions. As detailed in a press release issued last week, PerkinElmer will distribute Nonlinear's full range of 1D, 2D and array software. Howeve...

Researcher uncovers details of how cancer spreads

When cancer spreads, people often die. That's why a lot of cancer research and drugs focus on the metabolic pathways that allow cancer to metastasize -- to spread from one part of the body to another. Cornell University researchers have now furthered understanding of how these pathways work. Their insights might aid future research on drug therapies that disrupt the sequence of events tha...

Defective immune system response to smallpox vaccine detailed in new study

Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), have identified a defect in the immune response of people with the skin condition atopic dermatitis that puts them at risk of developing serious complications following smallpox vaccination. Led by Donald Y.M. Leung, M.D., Ph.D., of the National Jewish Medica...

Research details how a virus hijacks cell signals to cause infection

A common virus that causes meningitis and heart inflammation takes a "back door" approach to evade natural barriers, then exploits biological signals to infect human cells. Broadening knowledge of how viruses cause infection, a new study describes elaborate methods that the virus has evolved to bypass the body's defenses. "This study helps to explain how group B coxsackieviruses infect cel...

High resolution 'snapshots' detail dynamics of a cocaine antibody

Cocaine-binding antibodies have shown some promise in their ability to neutralize cocaine toxicity, but their binding ability is severely impaired by high concentrations of the drug. A catalytic monoclonal antibody such as 7A1, on the other hand, has the ability to regenerate after each new dose of the drug, making it far more effective than others in metabolizing cocaine. The study, which...

More>>

detail at Biology Products
detail at Biology Technology

Madison-area high-tech directory details 394 firms

MG&E has released its 2005 Greater Madison Area Directory of High Tech Companies, a desk reference to 394 area firms. WTN's Mike Klein takes you inside this valuable resource for anyone doing business in Wisconsin. <a href="http://www.wistechnology.com/article....
detail at Medicine News

Details Of Heart Failure Discovered

Canadian researchers have found out how the heart fails, and hope that this may make it easier to treat //the condition. The researchers have worked to find out how the metabolic pathways differentiate in healthy versus failing hearts. They had found that in the early stages of heart failure, the heart uses too much fatty acid and not enough carbohydrate; and then, later, it doesn't us...

Details of Cosmetic Surgery in a Special Website.

Cosmetic surgery is a burgeoning field and people now a days need to be aware of the various options available. Hence a website which gives exclusive information about //cosmetic surgery and the associated treatments is loaded in the net. The Department of Health says this website will provide details about the risks and the possible outcomes. At present cosmetic surgery is no...

A Detail Analysis of Head and Neck Cancer

The discovery of the molecular mechanism behind the aggressive head and neck cancer was unveiled by the researchers at the San Francisco VA Medical Center (SFVAMC). // It is a highly malignant form of cancer with a very high death rate. They have discovered the triple interaction between CD44, hyaluronan (HA), and LARG. CD44 is a surface receptor molecule that plays an important role in...

Autoimmune disorders studied in detail by U-M researchers.

University of Michigan researchers have been able to zero in (on) the modalities of a drug, capable of rectifying autoimmune disorders and other types of diseases. // Clinical trials on animal models have revealed the capacity of the drug to reduce the potency of a key enzyme, in charge of energy production. 'Many drugs block the function of enzymes, essentially turning them off,' sai...

Fat metabolism in fish to be studied in detail

Canterbury University researcher Dr Victoria Metcalf is out to delve into the Antarctic seas for some answers about fish. Metcalf will use the genetic filter technology// to understand how fish actually metabolize fat. This study will aid in the understanding of the existing connection between fat metabolism and heart disease. According to Metcalf, Antarctic fish metabolize fat for fu...

More>>

detail at Medicine Products
detail at Medicine Technology

MIV Therapeutics Announces Renowned Researcher to Detail Milestone Pre-Clinical Results at Prominent International Conference EuroPCR 2007

ATLANTA--(BUSINESS WIRE)--May 22, 2007 - MIV Therapeutics(OTCBB:MIVT) (FWB:MIV), a leading developer of next generationbiocompatible coatings and advanced drug delivery systems forCardiovascular stents and other implantable medical devices, ispleased to announce that results from an animal trial comparing itsproprietary polymer free Hydroxyapatite-coated drug-elutingcardiovascular stent to...

AEterna Zentaris' Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting

Ozarelix improved LUTS symptoms and urine flow over 28-week period QUEBEC CITY, May 23, 2007 /PRNewswire-FirstCall/ - AEternaZentaris Inc. , a global biopharmaceutical company focused onendocrine therapy and oncology, today announced that its partnerSpectrum Pharmaceuticals presented an abstract outlining detailedPhase 2 results for AEterna Zentaris' fourth-generation luteinizinghormone-r...

Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN

Interim analysis of Phase 2 comparative study showed significantresults in favor of alemtuzumab versus Rebif CAMBRIDGE, Mass. and WAYNE, N.J., May 02, 2007/PRNewswire-FirstCall/ -- Genzyme Corporation and Bayer HealthCarePharmaceutical today announced detailed interim results from theCAMMS223 Phase 2 study. This interim analysis of all patient datathrough at least twenty-four months from...
Other TagsEAGEAGEAGEAGWIFKORKORBCABCAEdgEdgEdgEdgEdg
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
(Date:10/9/2008)... WASHINGTON, D.C., October 9, 2008 The Indonesia...nnounced a bold commitment to protect the remainin...ndonesian island that holds some of the world,s mo...agreement represents the first-ever island-wide co...y. , The commitment has been endorsed by governo...
(Date:10/9/2008)..., RIVERSIDE, Calif. Essential for life in h... diseases such as rickets and osteoporosis, is now...verall human health, emphasizes UC Riverside,s An...D. , In a paper published in the August issue of...orman identifies vitamin D,s potential for contrib...
(Date:10/9/2008)..., A UC San Diego engineer has revealed a new mod...ipples of slime to crawl upside down beneath the s...echanical and aerospace engineering at the Jacobs ...in the journal Physics of Fluid called "Crawling..." that explains how and why water snails can drag ...
(Date:10/9/2008)... Work by researchers at North Carolina State Univ...lue crabs grown and harvested from freshwater pond...n,t worry, researchers say, because the pond-raise...d brethren. , North Carolina,s native blue crab ...r. Dave Eggleston, director of NC State,s Center f...
Breaking Biology News(10 mins):Saving Sumatra: Indonesia reaches historic agreement 2Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist 2Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist 3Ripple effect: Water snails offer new propulsion possibilities 2Ripple effect: Water snails offer new propulsion possibilities 3Turning freshwater farm ponds into crab farms 2Barr Subsidiary Sues Watson for SEASONIQUE 28R 29 Patent Infringement 3729 1Barr Subsidiary Sues Watson for SEASONIQUE 28R 29 Patent Infringement 3729 2Barr Subsidiary Sues Watson for SEASONIQUE 28R 29 Patent Infringement 3729 3Barr Subsidiary Sues Watson for SEASONIQUE 28R 29 Patent Infringement 3729 4Hospitals still not smoke free 13512 1Hospitals still not smoke free 13512 2Rogers Reaches Deal with Sports O Zone 13507 1Rogers Reaches Deal with Sports O Zone 13507 2DermTech Adds Allan C Halpern MD Chief of Dermatology at Memorial Sloan Kettering Cancer Center to Companys Melanoma Advisory Board 13502 1DermTech Adds Allan C Halpern MD Chief of Dermatology at Memorial Sloan Kettering Cancer Center to Companys Melanoma Advisory Board 13502 2
Other Contentsdimerdimerdimerdisulfidedisulfidedisulfidehelixhelixhelixhelixhelixdoubledoubledoubledoubledoubledoubledoubledoubledoubledowndowndowndowndowndowndowndowndowndowndrugdrugdrugdrugdrugdrugdrugdrugdrugdrug